Jupiter Neurosciences, Inc. stockholders' 2026 Annual Meeting results show that stockholders' approval of an amendment to the certificate of incorporation to effect a reverse stock split between 1:10 and 1:100 ratio. Additionally, stockholders' approval of an amendment to the 2025 Equity Incentive Plan to increase the following: 12.5 million SEPA Shares issued to Yorkville pursuant to the SEPA, 5,250,000 shares of common stock available for sale under the share incentive plan. Jupiter Neurosciences, Inc. is a healthcare company that develops neurosciences.**
